Therefore, this study aims to determine the prevalence of the FCGR2A (131H/R) and FCGR3A (158F/V) gene polymorphisms in children with primary ITP admitted to four major hospitals in the West Bank/Palestine between 2019 and 2023. The gene discussed is FCGR2A; the disease is autoimmune thrombocytopenic purpura.